NEW YORK, Aug. 19, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals Inc. ("Regeneron" or the "Company") (NASDAQ: REGN). The investigation concerns whether Regeneron and certain of its officers and/or directors have breached...
from PR Newswire: https://ift.tt/3hdGI6L
No comments:
Post a Comment